Entrada Therapeutics Statistics
NASDAQ: TRDAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
5.61+0.19 (+3.51%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Entrada Therapeutics by the numbers
Entrada Therapeutics has a market capitalization of $218.4 million based on 38.94M shares outstanding. With trailing EPS of $-3.96, Entrada Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 18.1% below its 50-day average and 39.5% below its 200-day average.
Average daily trading volume is 362.82K shares, or about $2.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TRDA valuation vs. peer median
| Metric | TRDA | Peer median | Difference |
|---|---|---|---|
| Market cap | $218.43M | $224.00M | -2% |
| Avg. volume | 362.82K | 410.59K | -12% |
Peer median across 8 companies: SION, NATR, KROS, EVMN, GLSI, MGNX, LYEL, IFRX.
Valuation
- Market cap
- $218.43M
- EPS (TTM)
- $-3.96
- Shares outstanding
- 38.94M
Price and trading
- Previous close
- 5.42
- Open
- 5.33
- Day range
- 5.32 – 5.66
- 52-week range
- 5.15 – 16.45
- 52-week change
- -4.10%
- Beta
- —
- Volume
- 297.44K
- Average volume
- 362.82K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 218.43M
- Forward Pe
- -1.86
- Eps
- -3.96
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 16.45
- Week52 Low
- 5.15
- Avg Volume
- 362.82K
- Shares Outstanding
- 38.94M
- Ma50
- 6.85
- Ma200
- 9.27
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -65.90%
- Pct From52w Low
- 8.93%